Related references
Note: Only part of the references are listed.Worldwide contamination of food-crops with mycotoxins: Validity of the widely cited 'FAO estimate' of 25%
Mari Eskola et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2020)
Mycotoxin exposure and human cancer risk: A systematic review of epidemiological studies
Liesel Claeys et al.
COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY (2020)
Current status of major mycotoxins contamination in food and feed in Africa
Haftom Kebede et al.
FOOD CONTROL (2020)
Predicting the Acute Liver Toxicity of Aflatoxin B1 in Rats and Humans by an In Vitro-In Silico Testing Strategy
Ixchel Gilbert-Sandoval et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2020)
Impact of Subacute Exposure to T-2 Toxin and Zearalenone on the Pharmacokinetics of Midazolam as CYP3A Probe Drug in a Porcine Animal Model: A Pilot Study
Wim Schelstraete et al.
FRONTIERS IN PHARMACOLOGY (2019)
Time-Course Effects of Acute Aflatoxin B1 Exposure on Hepatic Mitochondrial Lipids and Oxidative Stress in Rats
Oluwakemi A. Rotimi et al.
FRONTIERS IN PHARMACOLOGY (2019)
Characterization of Porcine Hepatic and Intestinal Drug Metabolizing CYP450: Comparison with Human Orthologues from A Quantitative, Activity and Selectivity Perspective
Wim Schelstraete et al.
SCIENTIFIC REPORTS (2019)
Biotransformation of the Mycotoxin Enniatin B1 by CYP P450 3A4 and Potential for Drug-Drug Interactions
Lada Ivanova et al.
METABOLITES (2019)
Mycotoxins in food and feed
Jelka Pleadin et al.
ADVANCES IN FOOD AND NUTRITION RESEARCH, VOL 89 (2019)
Outbreak of an acute aflatoxicosis in Tanzania during 2016
A. Kamala et al.
WORLD MYCOTOXIN JOURNAL (2018)
Prediction of cytochrome P450-mediated drug clearance in humans based on the measured activities of selected CYPs
Jie Gao et al.
BIOSCIENCE REPORTS (2017)
Mechanistic Modeling to Predict Midazolam Metabolite Exposure from In Vitro Data
Hoa Q. Nguyen et al.
DRUG METABOLISM AND DISPOSITION (2016)
Interindividual Variability in Cytochrome P450-Mediated Drug Metabolism
Timothy S. Tracy et al.
DRUG METABOLISM AND DISPOSITION (2016)
Expression of Bama Minipig and Human CYP3A Enzymes: Comparison of the Catalytic Characteristics with Each Other and Their Liver Microsomes
Yicong Bian et al.
DRUG METABOLISM AND DISPOSITION (2015)
Inhibition of Baicalin on Metabolism of Phenacetin, a Probe of CYP1A2, in Human Liver Microsomes and in Rats
Na Gao et al.
PLOS ONE (2014)
Optimization of the in vitro oxidative biotransformation of glimepiride as a model substrate for cytochrome p450 using factorial design
Dipti B. Ruikar et al.
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
PHASE II DRUG METABOLIZING ENZYMES
Petra Jancova et al.
BIOMEDICAL PAPERS-OLOMOUC (2010)
Prediction of Human Intestinal First-Pass Metabolism of 25 CYP3A Substrates from In Vitro Clearance and Permeability Data
Michael Gertz et al.
DRUG METABOLISM AND DISPOSITION (2010)
Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver
Xia Yang et al.
GENOME RESEARCH (2010)
Comparison between recombinant P450s and human liver microsomes in the determination of cytochrome P450 Michaelis-Menten constants
K. Youdim et al.
XENOBIOTICA (2010)
Effects of Chlorophyll and Chlorophyllin on Low-Dose Aflatoxin B1 Pharmacokinetics in Human Volunteers
Carole Jubert et al.
CANCER PREVENTION RESEARCH (2009)
Polymorphism of human cytochrome P450 enzymes and its clinical impact
Shu-Feng Zhou et al.
DRUG METABOLISM REVIEWS (2009)
Cytochrome P450 systems - biological variations of electron transport chains
Frank Hannemann et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2007)
Efficient activation of aflatoxin B1 by cytochrome P450 2A13, an enzyme predominantly expressed in human respiratory tract
XY He et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions
R Yuan et al.
DRUG METABOLISM AND DISPOSITION (2002)
Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: An application of serum incubation method
Y Shibata et al.
DRUG METABOLISM AND DISPOSITION (2002)
Assessment of specificity of eight chemical inhibitors using cDNA-expressed cytochromes P450
Y Sai et al.
XENOBIOTICA (2000)
Share Paper
